| | Biological therapies | Year 1 | Year 2 |
| | Abatacept (250 mg vial) | 1st 6 months | 2nd 6 months | 1st 6 months | 2nd 6 months | | Estimated number of vials per year | 37.8 | | 35.1 | | | Infusion cost/IV infusion | 56.69 € | | 56.69 € | | | Estimated reimbursement cost per year | 13,449.86 € | | 12,489.15 € | | | Estimated cost per six months (26 weeks) | 6,724.93 € | 6,724.93 € | 5,764.22 € | 6,724.93 € |
| | Adalimumab (40 mg syringe) | 1st 6 months | 2nd 6 months | 1st 6 months | 2nd 6 months | | Estimated number of prefilled syringes per year | 26 | | 26 | | | Estimated reimbursement cost per year | 13,367.77 € | | 13,367.77 € | | | Estimated cost per six months (26 weeks) | 6,683.89 € | 6,683.89 € | 6,683.89 € | 6,683.89 € |
| | Etanercept (25 mg vial) | 1st 6 months | 2nd 6 months | 1st 6 months | 2nd 6 months | | Estimated number of vials per year | 104 | | 104 | | | Estimated reimbursement cost per year | 12,313.86 € | | 12,313.86 € | | | Estimated cost per six months (26 weeks) | 6,156.93 € | 6,156.93 € | 6,156.93 € | 6,156.93 € |
| | Infliximab (100 mg vial) | 1st 6 months | 2nd 6 months | 1st 6 months | 2nd 6 months | | Estimated number of vials per year | 11.5 | 8.1 | 8.8 | 8.8 | | Infusion cost/IV infusion | 56.69 € | | 56.69 € | | | Estimated reimbursement cost per year | 10,966.75 € | | 9,794.14 € | | | Estimated cost per six months (26 weeks) | 6,446.38 € | 4,520.37 € | 4,897.07 € | 4,897.07 € |
| | Rituximab (500 mg vial) | 1st 6 months | 2nd 6 months | 1st 6 months | 2nd 6 months | | Estimated number of vials per year | 8.00 | | 8.00 | | | Infusion cost/IV infusion | 56.69 € | | 56.69 € | | | Estimated reimbursement cost per year | 10,202.76 € | | 10,202.76 € | | | Estimated cost per six months (26 weeks) | 5,101.38 € | 5,101.38 € | 5,101.38 € | 5,101.38 € |
|
|
